Advanced search
Publication Cover
Expert Review of Clinical Pharmacology Volume 6, 2013 - Issue 5
Submit an article Journal homepage
865
Views
42
CrossRef citations to date
0
Altmetric
Reviews

Update on current and future novel therapies for dry age-related macular degeneration

Ella LeungDepartment of Ophthalmology, New York Eye and Ear Infirmary, NY, USA
&
Gennady LandaDepartment of Ophthalmology, New York Eye and Ear Infirmary, NY, USA;Department of Ophthalmology, New York Medical College, Valhalla, NY, USACorrespondence[email protected]
Pages 565-579 | Published online: 10 Jan 2014

References

  • Schmier JK, Covert DW, Lau EC. Patterns and costs associated with progression of age-related macular degeneration. Am. J. Ophthalmol. 154(4), 675–681 (2012).
  • Rosenfeld PJ, Brown DM, Heier JS et al. Ranibizumab for neovascular age-related macular degeneration. N. Engl. J. Med. 355(14), 1419–1431 (2006).
  • Ma L, Dou HL, Huang YM et al. Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial. Am. J. Ophthalmol. 154(4), 625–634 (2012).
  • Damico FM, Gasparin F, Scolari MR, Pedral LS, Takahashi BS. New approaches and potential treatments for dry age-related macular degeneration. Arq. Bras. Oftalmol. 75(1), 71–76 (2012).
  • Mullins RF, Russell SR, Anderson DH, Hageman GS. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEBJ. 14(7), 835–846 (2000).
  • Wong WT, Kam W, Cunningham D et al. Treatment of geographic atrophy by the topical administration of OT-551: results of a phase II clinical trial. Invest. Ophthalmol. Vis. Sci. 51(12), 6131–6139 (2010).
  • Bradley DT, Zipfel PF, Hughes AE. Complement in age-related macular degeneration: a focus on function. Eye 25(6), 683–693 (2011).
  • Souied EH, Delcourt C, Querques G et al. Oral Docosahexaenoic acid in the prevention of exudative age-related macular degeneration: the nutritional AMD Treatment 2 Study. Ophthalmology ( Epub ahead of print) (2013).
  • Homma K, Okamoto S, Mandai M et al. Developing rods transplanted into the degenerating retina of Crx-knockout mice exhibit neural activity similar to native photoreceptors. Stem Cells 31(6), 1149–1159 (2013).
  • Schwartz SD, Hubschman JP, Heilwell G et al. Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379(9817), 713–720 (2012).
  • Jonas JB, Witzens-Harig M, Arseniev L, Ho AD. Intravitreal autologous bone-marrow-derived mononuclear cell transplantation. Acta Ophthalmol. 88(4), e131–e132 (2008).
  • Pulido J, Sanders D, Winters JL, Klingel R. Clinical outcomes and mechanism of action for rheopheresis treatment of age-related macular degeneration (AMD). J. Clin. Apher. 20(3), 185–194 (2005).
  • Pulido JS, Winters JL, Boyer D. Preliminary analysis of the final multicenter investigation of rheopheresis for age related macular degeneration (AMD) trial (MIRA-1) results. Trans. Am. Ophthalmol. Soc. 104, 221–231 (2006).
  • Rencova E, Blaha M, Studnicka J et al. Haemorheopheresis could block the progression of the dry form of age-related macular degeneration with soft drusen to the neovascular form. Acta Ophthalmol. 89(5), 463–471 (2011).
  • Koss MJ, Kurz P, Tsobanelis T et al. Prospective, randomized, controlled clinical study evaluating the efficacy of Rheopheresis for dry age-related macular degeneration. Dry AMD treatment with Rheopheresis Trial-ART. Graefes Arch. Clin. Exp. Ophthalmol. 247(10), 1297–1306 (2009).
  • Hooper P, Jutai JW, Strong G, Russell-Minda E. Age-related macular degeneration and low-vision rehabilitation: a systematic review. Can. J. Ophthalmol. 43(2), 180–187 (2008).
  • Gill K, Mao A, Powell AM, Sheidow T. Digital reader vs print media: the role of digital technology in reading accuracy in age-related macular degeneration. Eye 27(5), 639–643 (2013).
  • Hudson HL, Lane SS, Heier JS et al. Implantable miniature telescope for the treatment of visual acuity loss resulting from end-stage age-related macular degeneration: 1-year results. Ophthalmology 113(11), 1987–2001 (2006).
  • Borrelli E, Diadori A, Zalaffi A, Bocci V. Effects of major ozonated autohemotherapy in the treatment of dry age related macular degeneration: a randomized controlled clinical study. Int. J. Ophthalmol. 5(6), 708–713 (2012).
  • Qin S, McLaughlin AP, De Vries GW. Protection of RPE cells from oxidative injury by 15-deoxy-delta12,14-prostaglandin J2 by augmenting GSH and activating MAPK. Invest. Ophthalmol. Vis. Sci. 47(11), 5098–5105 (2006).
  • Ladewig MS, Ladewig K, Guner M, Heidrich H. Prostaglandin E1 infusion therapy in dry age-related macular degeneration. Prostaglandins Leukot. Essent. Fatty Acids, 72(4), 251–256 (2005).
  • Augustin AJ, Diehm C, Grieger F, Bentz J. Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial. Expert Opin. Investig. Drugs 22(7), 803–812 (2013).
  • Newsome DA. A randomized, prospective, placebo-controlled clinical trial of a novel zinc-monocysteine compound in age-related macular degeneration. Curr. Eye Res. 33(7), 591–598 (2008).
  • Piccardi M, Marangoni D, Minnella AM et al. A longitudinal follow-up study of saffron supplementation in early age-related macular degeneration: sustained benefits to central retinal function. Evid. Based Complement Alternat. Med. 9(2012).
  • Sangiovanni JP, Agron E, Meleth AD et al {omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am. J. Clin. Nutr. 90(6), 1601–1607 (2009).
  • Chew EY, Clemons TE, Agron E et al. Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS Report No. 35. Ophthalmology (2013) ( Epub ahead of print).
  • Zeng S, Hernandez J, Mullins RF. Effects of antioxidant components of AREDS vitamins and zinc ions on endothelial cell activation: implications for macular degeneration. Invest. Ophthalmol. Vis. Sci. 53(2), 1041–1047 (2012).
  • Eller AW, Gorovoy IR, Mayercik VA. Yellow corneal ring associated with vitamin supplementation for age-related macular degeneration. Ophthalmology 119(5), 1011–1016 (2012).
  • Chew EY, Clemons TE, SanGiovanni JP et al. Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA 309(19), 2005–2015 (2013).
  • Li Y, Tao W, Luo L et al. CNTF induces regeneration of cone outer segments in a rat model of retinal degeneration. PLoS ONE 5(3), e9495 (2010).
  • Kauper K, McGovern C, Sherman S et al. Two-year intraocular delivery of ciliary neurotrophic factor by encapsulated cell technology implants in patients with chronic retinal degenerative diseases. Invest. Ophthalmol. Vis. Sci. 53(12), 7484–7491 (2012).
  • Zhang K, Hopkins JJ, Heier JS et al. Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration. Proc. Natl Acad. Sci. USA 108(15), 6241–6245 (2011).
  • Mata NL, Lichter JB, Vogel R, Han Y, Bui TV, Singerman LJ. Investigation of oral fenretinide for treatment of geographic atrophy in age-related macular degeneration. Retina 33(3), 498–507 (2013).
  • Dobri N, Qin Q, Kong J et al. A1120, a nonretinoid RBP4 antagonist, inhibits formation of cytotoxic bisretinoids in the animal model of enhanced retinal lipofuscinogenesis. Invest. Ophthalmol. Vis. Sci. 54(1), 85–95 (2013).
  • Salehi-Had H, Puliafito CA. Fenretinide-associated multilayered retinal hemorrhage in a patient with hairy cell leukemia. Ophthalmic. Surg. Lasers Imaging 41(Suppl.), S89–S92 (2010).
  • Maeda T, Maeda A, Matosky M et al. Evaluation of potential therapies for a mouse model of human age-related macular degeneration caused by delayed all-trans-retinal clearance. Invest. Ophthalmol. Vis. Sci. 50(10), 4917–4925 (2009).
  • Tate DJ, Newsome DA. A novel zinc compound (zinc monocysteine) enhances the antioxidant capacity of human retinal pigment epithelial cells. Curr. Eye Res. 3(7–8), 675–683 (2006).
  • Leung KW, Liu M, Xu X, Seiler MJ, Barnstable CJ, Tombran-Tink J. Expression of ZnT and ZIP zinc transporters in the human RPE and their regulation by neurotrophic factors. Invest. Ophthalmol. Vis. Sci. 49(3), 1221–1231 (2008).
  • Murray IJ, Makridaki M, van der Veen RL, Carden D, Parry NR, Berendschot TT. Lutein supplementation over a one-year period in early AMD might have a mild beneficial effect on visual acuity: the CLEAR study. Invest. Ophthalmol. Vis. Sci. 5(3), 1781–1788 (2013).
  • Rutar M, Natoli R, Albarracin R, Valter K, Provis J. 670-nm light treatment reduces complement propagation following retinal degeneration. J. Neuroinflammation 9, 257 (2012).
  • Parodi MB, Virgili G, Evans JR. Laser treatment of drusen to prevent progression to advanced age-related macular degeneration. Cochrane Database Syst. Rev. 3, CD006537 (2009).
  • Owens SL, Bunce C, Brannon AJ, Wormald R, Bird AC. Prophylactic laser treatment appears to promote choroidal neovascularisation in high-risk ARM: results of an interim analysis. Eye 17(5), 623–627 (2003).
  • Cahill MT, Mruthyunjaya P, Bowes Rickman C, Toth CA. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degrees peripheral retinectomy for geographic atrophy. Arch. Ophthalmol. 123(7), 935–938 (2005).
  • Barber AC, Hippert C, Duran Y et al. Repair of the degenerate retina by photoreceptor transplantation. Proc. Natl Acad. Sci. USA 110(1), 354–359 (2013).
  • Caramoy A, Liakopoulos S, Menrath E, Kirchhof B. Autologous translocation of choroid and retinal pigment epithelium in geographic atrophy: long-term functional and anatomical outcome. Br. J. Ophthalmol. 94(8), 1040–1044 (2010).
  • Algvere PV, Berglin L, Gouras P, Sheng Y, Kopp ED. Transplantation of RPE in age-related macular degeneration: observations in disciform lesions and dry RPE atrophy. Graefes Arch. Clin. Exp. Ophthalmol. 235(3), 149–158 (1997).
  • Treumer F, Bunse A, Klatt C, Roider J. Autologous retinal pigment epithelium-choroid sheet transplantation in age related macular degeneration: morphological and functional results. Br. J. Ophthalmol. 91(3), 349–353 (2007).
  • Landa G, Rosen RB, Patel A et al. Qualitative spectral OCT/SLO analysis of drusen change in dry age-related macular degeneration patients treated with Copaxone. J. Ocul. Pharmacol. Ther. 27(1), 77–82 (2011).
  • Feher J, Kovacs B, Kovacs I, Schveoller M, Papale A, Balacco Gabrieli C. Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10. Ophthalmologica 219(3), 154–166 (2005).
  • Birch DG, Toler SM, Swanson WH, Fish GE, Laties AM. A double-blind placebo-controlled evaluation of the acute effects of sildenafil citrate (Viagra) on visual function in subjects with early-stage age-related macular degeneration. Am. J. Ophthalmol. 133(5), 665–672 (2002).
  • Azzouni F, Abu Samra K. Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature. J. Sex Med. 8(10), 2894–2903 (2011).
  • Pemp B, Garhofer G, Lasta M, Schmidl D, Wolzt M, Schmetterer L. The effects of moxaverine on ocular blood flow in patients with age-related macular degeneration or primary open angle glaucoma and in healthy control subjects. Acta Ophthalmol. 90(2), 139–145 (2012).
  • Evans JR. Ginkgo biloba extract for age-related macular degeneration. Cochrane Database Syst. Rev. 2, CD001775 (2000).
  • Chi ZL, Yoshida T, Lambris JD, Iwata T. Suppression of drusen formation by compstatin, a peptide inhibitor of complement C3 activation, on cynomolgus monkey with early-onset macular degeneration. Adv. Exp. Med. Biol. 703, 127–135 (2010).
  • Lockington D, Imrie F, Gillen J, Fitzpatrick A, Willison H. Visual improvement in established central retinal vein occlusion with long-standing macular edema following systemic eculizumab treatment. Cancer J. Ophthalmol. 45(6), 649 (2010).
  • Collier RJ, Wang Y, Smith SS et al. Complement deposition and microglial activation in the outer retina in light-induced retinopathy: inhibition by a 5-HT1A agonist. Invest. Ophthalmol. Vis. Sci. 52(11), 8108–8116 (2011).
  • Emerson MV, Lauer AK. Current and emerging therapies for the treatment of age-related macular degeneration. Clin. Ophthalmol. 2(2), 377–388 (2008).
  • Christen WG, Glynn RJ, Sesso HD et al. Vitamins E and C and medical record-confirmed age-related macular degeneration in a randomized trial of male physicians. Ophthalmology 119(8), 1642–1649 (2012).
  • Kubota R, Boman NL, David R, Mallikaarjun S, Patil S, Birch D. Safety and effect on rod function of ACU-4429, a novel small-molecule visual cycle modulator. Retina 32(1), 183–188 (2012).
  • Blumenkranz MS, Leung LS, Martin DF et al. Pharmacotherapy of age-related macular degeneration. In: Retina (5th Edition). Ryan SJ, Schachat AP, Wilkinson CP, Hinton DR, Sadda S, Wiedemann P (Eds). Saunders London, UK (2013).
  • Rohrer B, Guo Y, Kunchithapautham K, Gilkeson GS. Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage. Invest. Ophthalmol. Vis. Sci. 48(11), 5282–5289 (2007).
  • Ding JD, Johnson LV, Herrmann R et al. Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc. Natl Acad. Sci. USA 108(28), E279–E287 (2011).
  • McGeer PL, Sibley J. Sparing of age-related macular degeneration in rheumatoid arthritis. Neurobiol. Aging 26(8), 1199–1203 (2005).
  • Pikkel J, Chassid O, Sharabi-Nov A, Beiran I. A retrospective evaluation of the effect of hydroxyquinine on RPE thickness. Graefes Arch. Clin. Exp. Ophthalmol. 251(7), 1687–1690 (2013).
  • Stieger K, Mendes-Madeira A, Meur GL et al. Oral administration of doxycycline allows tight control of transgene expression: a key step towards gene therapy of retinal diseases. Gene Ther. 14(23), 1668–1673 (2007).
  • Mellwig KP. Heparin-induced extracorporeal low-density lipoprotein precipitation. Ther. Apher. Dial. 7(3), 365–369 (2003).
  • Rezaie T, McKercher SR, Kosaka K et al. Protective effect of carnosic acid, a pro-electrophilic compound, in models of oxidative stress and light-induced retinal degeneration. Invest. Ophthalmol. Vis. Sci. 53(12), 7847–7854 (2012).
  • Wang LL, Sun Y, Huang K, Zheng L. Curcumin, a potential therapeutic candidate for retinal diseases. Mol. Nutr. Food. Res. doi:10.1002/mnfr.201200718 (2013) ( Epub ahead of print).
  • Brown MM, Brown GC, Stein JD, Roth Z, Campanella J, Beauchamp GR. Age-related macular degeneration: economic burden and value-based medicine analysis. Cancer J. Ophthalmol. 40(3), 277–287 (2005).
  • Cong R, Zhou B, Sun Q, Gu H, Tang N, Wang B. Smoking and the risk of age-related macular degeneration: a meta-analysis. Ann. Epidemiol. 18(8), 647–656 (2008).
  • Cougnard-Gregoire A, Delyfer MN, Korobelnik JF et al. Long-term blood pressure and age-related macular degeneration: the ALIENOR study. Invest. Ophthalmol. Vis. Sci. 54(3), 1905–1912 (2013).
  • Zhu W, Wu Y, Xu D et al. Aspirin use and risk of age-related macular degeneration: a meta-analysis. PLoS ONE 8(3), e58821 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.